参考文献/References:
[1]刘湘慧,斯韬,梁婷,等.铁死亡发生机制及其在肝细胞癌中的作用研究进展[J].陕西医学杂志,2023,52(3):354-357.
[2]马志红,廉猛,苏才丽,等.铁死亡与肿瘤的研究进展[J].临床与实验病理学杂志,2018,34(11):1247-1251.
[3]JIANG X,STOCKWELL B R,CONRAD M.Ferroptosis:Mechanisms,biology and role in disease[J].Nat Rev Mol Cell Biol,2021,22(4):266-282.
[4]LI J,CAO F,YIN H L,et al.Ferroptosis:Past,present and future[J].Cell Death Dis,2020,11(2):88.
[5]SHA W,HU F,XI Y,et al.Mechanism of ferroptosis and its role in type 2 diabetes mellitus[J].J Diabetes Res,2021,2021:9999612.
[6]LI D,JIANG C,MEI G,et al.Quercetin alleviates ferroptosis of pancreatic β cells in type 2 diabetes[J].Nutrients,2020,12(10):2954.
[7]MIIKI A,RICORDI C,SAKUMA Y,et al.Divergent antioxidant capacity of human islet cell subsets:A potential cause of beta-cell vulnerability in diabetes and islet transplantation[J].PLoS One,2018,13(5):e196570.
[8]BRUNI A,PEPPER A R,PAWLICK R L,et al.Ferroptosis-inducing agents compromise in vitro human islet viability and function[J].Cell Death Dis,2018,9(6):595.
[9]HAEEISON A V,LORENZO F R,MCCLAIN D A.Iron and the pathophysiology of diabetes[J].Annu Rev Physiol,2023,85:339-362.
[10]MENG Z,LIANG H,ZHAO J,et al.HMOX1 upregulation promotes ferroptosis in diabetic atherosclerosis[J].Life Sci,2021,284:119935.
[11]WANG H,LIU D,ZHENG B,et al.Emerging role of ferroptosis in diabetic kidney disease:Molecular mechanisms and therapeutic opportunities[J].Int J Biol Sci,2023,19(9):2678-2694.
[12]WANG X,CHEN X,ZHOU W,et al.Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways[J].Acta Pharm Sin B,2022,12(2):708-722.
[13]李浩甲,杨文曲,韩冲芳,等.去铁胺对糖尿病大鼠心肌细胞铁死亡通路的影响[J].医学研究杂志,2020,49(9):116-119.
[14]FRIEDMANNANGELI J P,SCHNEIDER M,PRONETH B,et al.Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice[J].Nat Cell Biol,2014,16(12):1180-1191.
[15]刘羽茜,刘悦,孙宇衡,等.基于脾脏象理论探讨脾与线粒体相关性[J].中华中医药学刊,2019,37(6):1362-1364.
[16]刘友章,王昌俊,周俊亮,等.长期脾虚模型大鼠细胞线粒体的研究[J].中医药学刊,2006,25(3):391-394.
[17]刘文宾,吴迪炯,叶宝东,等.慢性再生障碍性贫血患者铁过载与中医血瘀证的相关性研究[J].中国中西医结合杂志,2018,38(1):38-41.
[18]吴迪炯,罗贇飞,刘文宾,等.慢性“髓劳”患者“血瘀证”与铁负荷过载的相关性研究[J].浙江中医药大学学报,2016,40(4):265-269.
[19]CHEN X,KANG R,KROEMER G,et al.Ferroptosis in infection,inflammation,and immunity[J].J Exp Med,2021,218(6):e20210518.
[20]SUN Y,CHEN P,ZHAI B,et al.The emerging role of ferroptosis in inflammation[J].Biomed Pharmacother,2020,127:110108.
[21]SALAMA S A,KABEL A M.Taxifolin ameliorates iron overload-induced hepatocellular injury:Modulating PI3K/AKT and p38 MAPK signaling,inflammatory response,and hepatocellular regeneration[J].Chem Biol Interact,2020,330:109230.
[22]熊曼琪,李惠林.脾虚是消渴病的重要病机[J].广州中医学院学报,1991,8(1):1-4.
[23]李乐愚,林慧,梅全喜,等.复方番石榴制剂对2型糖尿病模型大鼠空腹血糖及胰岛素敏感性的影响[J].时珍国医国药,2015,26(11):2644-2646.
[24]成金燕,李乐愚,林泽宏,等.复方番石榴制剂治疗超重肥胖2型糖尿病的疗效分析[J].广州中医药大学学报,2016,33(5):630-633.
[25]徐瑞颜,成金燕,李乐愚.复方番石榴合剂治疗超重肥胖型2型糖尿病疗效及对患者肠黏膜屏障功能的影响[J].陕西中医,2022,43(8):1045-1048.
[26]王泽,林兰,李晓文,等.中医药干预糖尿病前期临床研究概况[J].中华中医药杂志,2021,36(4):2191-2195.
[27]刘友章,王昌俊,刘静,等.四君子汤对脾虚大鼠肝、心肌、胃黏膜和骨骼肌细胞线粒体损伤的修复作用[J].中国临床康复,2006,(39):170-173,193.
[28]XIE D,LI K,FENG R,et al.Ferroptosis and traditional Chinese medicine for type 2 diabetes mellitus[J].Diabetes Metab Syndr Obes,2023,16:1915-1930.
[29]王向晶,周奕菁,黄科,等.参芪地黄汤通过GPX4信号通路调控糖尿病肾病小鼠铁死亡的机制研究[J].浙江中医药大学学报,2024,48(4):407-415.
[30]段航,曾凡,王林华,等.桃红四物汤调控Nrf2/Keap1/HO-1信号通路介导的铁死亡在膝骨关节炎中的作用机制[J].中药药理与临床,2024,40(7):10-15.
[31]杨芳,高素文,刘旋,等.丹参酮ⅡA通过调控p38MAPK/NF-κB信号通路减轻糖尿病雄性大鼠生殖损伤实验研究[J].陕西医学杂志,2024,53(5):610-615.
[32]岳星.化瘀祛湿方对早中期KOA铁死亡相关基因VEGFA、IL-6的影响[D].南宁:广西中医药大学,2024.
[33]张志达.黄芩素调控SLC7A11/GPX4轴抑制铁死亡预防糖尿病性骨质疏松的机制[D].广州:广州中医药大学,2022.
[34]刘清,王芳,张淑娟,等.白虎加人参汤对2型糖尿病大鼠抗氧化应激作用及机制研究[J].陕西中医,2024,45(9):1166-1171.
[35]黄璟夷,林俊,钟玉娇,等.葛根芩连汤对2型糖尿病合并非酒精性脂肪肝大鼠模型铁死亡干预作用研究[J].环球中医药,2024,17(7):1291-1298.
相似文献/References:
[1]李向辉,卢文杰.葛黄降糖汤治疗2型糖尿病合并颈动脉硬化临床研究*[J].陕西中医,2019,(5):580.
LI Xianghui,LU Wenjie..Effect of Gehuang Jiangtang decoction on mellitus complicated with carotid arteriosclerosis in type 2 diabetes patients[J].,2019,(8):580.
[2]杨斯皓,马方霞,詹 云.一贯煎合六味地黄汤配合西药治疗2型糖尿病合并非酒精性脂肪肝临床疗效及对患者生活质量的评价*[J].陕西中医,2019,(8):1006.
YANG Sihao,MA Fangxia,ZHAN Yun..Clinical efficacy and quality of life evaluation of Yiguanjian plus Liuwei Dihuang decoction with western medicine in the treatment of type 2 diabetes with nonalcoholic fatty liver disease[J].,2019,(8):1006.
[3]孙晓红,陈学彬△.芪精丹兰汤对伴有左心室舒张功能不全的2型糖尿病合并代谢综合征患者糖脂代谢、心率变异性的影响*[J].陕西中医,2019,(10):1336.
SUN Xiaohong,CHEN Xuebin..Effect of Qijing Danlan decoction on glucose and lipid metabolism and heart rate variability in patients with type 2 diabetes mellitus complicated with MS with left ventricular diastolic dysfunction[J].,2019,(8):1336.
[4]訾 璐,胡小军△,王 玉,等.针刺中脘穴联合自拟茶方对2型糖尿病患者血糖水平的影响*[J].陕西中医,2019,(10):1460.
ZI Lu,HU Xiaojun,WANG Yu,et al.Effect of zhong wan acupuncture combined with selfdesigned tea prescription on blood glucose level in patients with type 2 diabetes mellitus[J].,2019,(8):1460.
[5]文启友,周 伶,马若梦,等.化瘀利尿法论治2型糖尿病探析[J].陕西中医,2021,(6):761.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.021]
[6]谢兆桃,周卓宁,郑 鹏,等.从中焦论治2型糖尿病患者餐后血糖波动[J].陕西中医,2021,(6):764.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.022]
[7]胡全穗,伍宗明.运用中药药对配伍优化消渴病中医防治方案临床研究[J].陕西中医,2021,(8):1084.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.024]
HU Quansui,WU Zongming.Clinical research on optimizing the TCM prevention and treatment of Xiaoke by using compatibility of herb-partners[J].,2021,(8):1084.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.024]
[8]卢 昉,刘晓霞,梁佩玲,等.清热益气降糖方对2型糖尿病患者胰岛α、β细胞功能的影响[J].陕西中医,2021,(10):1400.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.019]
[9]刘厚利,呼兴华,何 莉,等.基于数据挖掘许建秦治疗湿热内蕴型糖尿病用药规律分析[J].陕西中医,2021,(10):1455.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.035]
[10]陈继玲,任珍珍,王劭敏,等.玉泉丸合生脉散联合二甲双胍治疗气阴两虚证2型糖尿病临床研究[J].陕西中医,2021,(11):1553.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]
CHEN Jiling,REN Zhenzhen,WANG Shaomin,et al.Efficacy of Yuquan pills with Shengmai powder and metformin tablets in the treatment of T2DM with deficiency of Qi and Yin[J].,2021,(8):1553.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]